TuesdayJun 30, 2020 3:30 pm

Psychedelic Stocks: Why Your Investment Portfolio Should Be Teeming With Them

This may sound unbelievable, but, despite the raging COVID-19 pandemic, great investment opportunities are still out there. By investment, we are not referring to companies which specialize in bulk-packaging toilet paper or churning out millions of gallons of sanitizer. Psychedelic medicine stocks are what we are talking about, and here are some compelling reasons why your investment portfolio needs to have these medicines. You’d Be Getting in Early Lots of people who invested in marijuana stocks are regretting their decision for one key reason; they joined the fray late in the game when marijuana stocks had nearly peaked, and the…

Continue Reading

TuesdayJun 30, 2020 10:00 am

Danish Researchers Discover Novel Way of Making Psilocybin from Kitchen Ingredient

Just as the immense potential of psilocybin is being recognized and accepted by the scientific community, researchers are already hard at work looking for new ways of making the chemical without having to rely on growing magic mushrooms on a large scale. To this end, a team of Danish researchers appears to have found an easy way to make this chemical by using yeast. The DTU Biosustain scientists discovered that a common species of yeast used in winemaking, brewing and baking can act as a host for psilocybin when this yeast is subjected to a process that the researchers refer…

Continue Reading

MondayJun 29, 2020 4:30 pm

3 Key Reasons Why Psychedelics Could Upset Big Pharmaceuticals

The early results from clinical studies on psychedelics have shown that these substances have immense potential to treat a number of mental disorders, and this has in turn triggered a major shift in public perception regarding these substances. One industry that is likely to follow these developments with a lot of interest is the pharmaceutical industry. Several reasons could explain why they have more than a casual interest in psychedelics. Psychedelics Could Cure Rather Than Provide Temporary Relief The existing pharmaceutical medications for mental disorders offer temporary relief at best, and have no effect in lots of cases. Additionally, the…

Continue Reading

MondayJun 29, 2020 10:00 am

Why Psychedelics Stocks May Currently Be Undervalued

Even before the COVID-19 pandemic sucker-punched the stock market, it was rather hard for investors to find worthwhile investment opportunities. It was therefore just a matter of time before a market correction occurred, and the coronavirus outbreak provided the trigger for this correction. However, as the markets nosedive, experienced investors know that such a correction presents new opportunities. One industry where there is huge potential for investors is the psychedelics sector. Just like the marijuana industry, psychedelics represent a novel way to treat not just mental but also physical ailments. However, that may be where the comparisons stop between those…

Continue Reading

FridayJun 26, 2020 4:00 pm

Psychedelics-Centered Clinics: What You Need to Know

As a potential investor in psychedelics, you may be wondering how firms will generate meaningful revenues from this industry given that the pharmaceutical and biotech industries are investment-heavy. Well, the answer to this question seems to be that psychedelics companies that operate treatment clinics stand a higher chance of having a revenue edge over those that don’t have clinics. Clinics are the logical way to go for psychedelic companies since, as anyone who has ever tried psychedelics will tell you, the psychedelic experience is a profound one that takes an individual on a journey into their own selves so that…

Continue Reading

FridayJun 26, 2020 10:00 am

Colorado Nonprofit Launches Education Campaign about Psychedelics

"Let's Talk about Psychedelics" is a campaign by The Nowak Society, a Colorado-based nonprofit focused on public sensitization on psychedelics. The Nowak Society has been making considerable strides in normalizing the previously nonexistent conversation on psychedelics. On May 7, 2019, Denver became the first U.S. city to decriminalize the use of psilocybin mushrooms and other plant-based entheogens. This groundbreaking development can partly be attributed to The Society for Psychedelics Outreach Reform and Education (SPORE) having its roots in the city. Several months later, Oakland and Santa Cruz followed and decriminalized plant-based entheogens. This has led to a nationwide movement of…

Continue Reading

ThursdayJun 25, 2020 2:00 pm

What Drives People to Use Psychedelic Substances

Hallucinogens are undoubtedly becoming more popular each day the world over. With the decriminalization of psilocybin and other plant-based entheogens in some cities such as Denver and Santa Cruz, one cannot help but wonder, 'Why do people use psychedelic substances?' Well, all the hype around psychedelics is not unfounded. There are many psychedelic substances, from 'magic' mushrooms (which contain psilocybin) to Peyote (which contains DMT), to LSD, which all differ in their hallucinogenic intensity. However, they all have one important use, recreation. After a long, dull day of work or when you're bored, eating some 'magic' mushrooms will guarantee you…

Continue Reading

ThursdayJun 25, 2020 10:00 am

Psychedelics Could Treat Physical Health Conditions

There is a general consensus in the research community that psychedelics have immense potential in the treatment of mental health conditions. As more scientists have picked interest in these substances, it is also becoming apparent that the therapeutic role of psychedelics could extend to treating physical health conditions that aren’t connected to one’s mental state. One big area where psychedelics could have numerous applications is in managing the inflammatory pathways responsible for several conditions afflicting humans. These disorders include those affecting the lungs, heart and the eyes. This exciting research is also focusing on the serotonin receptors, just as the…

Continue Reading

WednesdayJun 24, 2020 3:00 pm

Take Your Pick: Synthetic Psilocybin or Magic Mushroom Pills?

Decades ago, psychedelics like “magic mushrooms” were viewed as the preserve of the counterculture crowd who would be spotted chomping away on woody stems and dry caps. Today, a new picture of laboratory-produced synthetic psilocybin pills is emerging and it could soon send the consumption mode of yesteryears into oblivion. How did we get here? In 1963, Albert Hoffman, the Swiss scientist who synthesized LSD, received a small package containing 100 grams of magic mushrooms. This package was a gift from Maria Sabina, a Mazateca healer who hailed from Southern Mexico. Hoffman immediately went to work in his lab, and…

Continue Reading

WednesdayJun 24, 2020 10:00 am

Mental Health Startup Aims to Help Patients Access Psychedelic Treatment

As the medical and scientific community embrace psychedelic treatment, and as regulators clear these treatments, a need has arisen to take prospective patients through the entire process so that they make informed decisions and know who to turn to for help. Osmind, a mental health startup, has risen to the occasion to provide the needed support. Osmind aims at creating a community for people seeking psychedelic treatments which have FDA-approval. Currently, only ketamine has this regulatory approval, but industry insiders expect similar approval to be given to psilocybin and MDMA. Osmind is building an app as well as an online…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050